Johnson & Johnson Innovation – JJDC

JJDC, Johnson & Johnson's corporate venture capital organization founded in 1973, invests across pharmaceuticals and medtech 'at all stages, from new company creation and seed-level startups to Series A and beyond, including private investments in public equity (PIPEs).' Guided by a clear, consistent investment strategy aligned with the scientific goals of Johnson & Johnson, JJDC works hand-in-hand with partners to help navigate the path to creating breakthrough health innovations, deploying the full capabilities of J&J including discovery, clinical development, regulatory affairs, manufacturing and commercialization. JJDC pursues opportunities to solve critical healthcare needs across therapeutics, medical devices, diagnostics, AI/ML and consumer healthcare. With over $3.2B in capital invested since 2016 and more than 100 active portfolio companies, JJDC takes a long-term, value-add approach—providing strategic direction, access to J&J's global expertise, and co-founding new companies alongside leading venture partners. The firm operates globally through Innovation Centers in Boston, San Francisco, London, and Shanghai, and the JLABS incubator network spanning 13+ locations worldwide.